Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Aromatase Inhibitor-Associated Arthralgias
NCT04754399Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Apr 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Aromatase inhibitor-associated arthralgia (AIA), sponsored by University of Michigan Rogel Cancer Center. Started Apr 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
Aromatase inhibitor-associated arthralgia (AIA)
Beyond the preview
Go deeper on NCT04754399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04754399.